2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
6
Thyroid Nodule
5
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Thyroid Neoplasms
3
Thyroid Cancer, Papillary
3
Uterine Cervical Dysplasia
2
Sarcoma
2
Prostatic Hyperplasia
2
Papillomavirus Infections
2
Melanoma
2
Liver Neoplasms
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder, Neurogenic
1
Urinary Bladder Neoplasms
1
Spinal Dysraphism
1
Spinal Cord Compression
1
Recurrence
1
Precancerous Conditions
1
Papillary Thyroid Microcarcinoma
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Unknown Primary
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Hypospadias
1
Interventions
Bevacizumab
19
Capecitabine
15
Oxaliplatin
11
Irinotecan
11
Cetuximab
11
Fluorouracil
10
Leucovorin
8
aflibercept
7
Panitumumab
6
trifluridine tipiracil drug combination
4
Nivolumab
4
sintilimab
3
regorafenib
3
Ipilimumab
3
Vemurafenib
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
HMPL-013
2
Folfox protocol
2
Drug Therapy
2
tremelimumab
1
spartalizumab
1
raltitrexed
1
pembrolizumab
1
monoclonal antibody YYB-101
1
masitinib
1
irinotecan sucrosofate
1
glucopyranosyl lipid-A
1
folfirinox
1
durvalumab
1
camrelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colorectal Cancer Metastatic
×
Transurethral Resection of Prostate
×
Clear all
NCT05129787
2026-02-12
NEW-COMET
Oslo University Hospital
Phase NA
Active not recruiting
230 enrolled